Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FAK inhibitors(Focal adhesion kinase inhibitors), PYK2 inhibitors(Focal adhesion kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis | Preclinical | IL | 10 Oct 2022 |